Cavium’s (CAVM) “Hold” Rating Reaffirmed at Canaccord Genuity

Cavium, Inc. (NASDAQ:CAVM)‘s stock had its “hold” rating reiterated by research analysts at Canaccord Genuity in a report released on Tuesday, July 11th. They presently have a $66.00 price target on the semiconductor provider’s stock. Canaccord Genuity’s target price would indicate a potential upside of 8.18% from the company’s current price.

Other equities research analysts have also issued reports about the stock. Argus raised their price objective on shares of Cavium from $75.00 to $82.00 and gave the company a “buy” rating in a report on Tuesday, March 14th. Jefferies Group LLC upgraded shares of Cavium from a “hold” rating to a “buy” rating and raised their price objective for the company from $73.00 to $79.00 in a report on Monday, July 10th. Needham & Company LLC restated a “buy” rating and issued a $78.00 price objective (up from $77.00) on shares of Cavium in a report on Thursday, April 27th. Longbow Research started coverage on shares of Cavium in a report on Friday, June 9th. They issued a “buy” rating and a $85.00 price objective on the stock. Finally, MKM Partners restated a “buy” rating and issued a $81.00 price objective (up from $77.00) on shares of Cavium in a report on Monday, May 1st. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and thirteen have given a buy rating to the company’s stock. Cavium currently has a consensus rating of “Buy” and a consensus target price of $74.53.

Shares of Cavium (CAVM) traded down 0.11% during trading on Tuesday, reaching $61.01. 807,184 shares of the company were exchanged. The firm has a 50-day moving average price of $64.41 and a 200-day moving average price of $68.03. Cavium has a 1-year low of $46.78 and a 1-year high of $76.26. The stock’s market capitalization is $4.16 billion.

Cavium (NASDAQ:CAVM) last announced its quarterly earnings data on Wednesday, August 2nd. The semiconductor provider reported $0.67 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.02. Cavium had a negative net margin of 22.82% and a positive return on equity of 5.87%. The business had revenue of $242.09 million for the quarter, compared to analyst estimates of $238.93 million. During the same period last year, the business earned $0.29 EPS. The company’s revenue was up 125.8% on a year-over-year basis. Equities research analysts predict that Cavium will post $2.79 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was first published by BBNS and is the property of of BBNS. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at https://baseballnewssource.com/markets/canaccord-genuity-reaffirms-hold-rating-for-cavium-inc-cavm-updated-updated-updated/1196209.html.

In other news, SVP Vincent P. Pangrazio sold 15,000 shares of Cavium stock in a transaction dated Tuesday, May 16th. The shares were sold at an average price of $75.73, for a total value of $1,135,950.00. Following the sale, the senior vice president now owns 60,039 shares of the company’s stock, valued at $4,546,753.47. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, VP Arthur D. Chadwick sold 40,000 shares of Cavium stock in a transaction dated Tuesday, May 16th. The shares were sold at an average price of $75.14, for a total transaction of $3,005,600.00. Following the completion of the sale, the vice president now directly owns 75,383 shares in the company, valued at approximately $5,664,278.62. The disclosure for this sale can be found here. 4.65% of the stock is owned by insiders.

Several hedge funds have recently modified their holdings of CAVM. IFP Advisors Inc increased its stake in shares of Cavium by 6.9% in the first quarter. IFP Advisors Inc now owns 1,559 shares of the semiconductor provider’s stock valued at $112,000 after buying an additional 101 shares during the last quarter. Solaris Asset Management LLC increased its stake in shares of Cavium by 52.4% in the first quarter. Solaris Asset Management LLC now owns 1,600 shares of the semiconductor provider’s stock valued at $115,000 after buying an additional 550 shares during the last quarter. US Bancorp DE increased its stake in shares of Cavium by 85.1% in the first quarter. US Bancorp DE now owns 1,888 shares of the semiconductor provider’s stock valued at $135,000 after buying an additional 868 shares during the last quarter. BNP Paribas Arbitrage SA increased its stake in Cavium by 107.3% in the second quarter. BNP Paribas Arbitrage SA now owns 2,579 shares of the semiconductor provider’s stock worth $160,000 after buying an additional 1,335 shares in the last quarter. Finally, Bluestein R H & Co. bought a new stake in Cavium during the first quarter worth approximately $215,000.

Cavium Company Profile

Cavium, Inc is a provider of integrated semiconductor processors that enable intelligent processing for wired and wireless infrastructure and cloud for networking, communications, storage and security applications. The Company’s products consist of multi-core processors for embedded and data center applications, network connectivity for server and switches, storage connectivity, and security processors for offload and appliance.

Analyst Recommendations for Cavium (NASDAQ:CAVM)

Receive News & Ratings for Cavium Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cavium Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Miami’s Giancarlo Stanton Sets Marlins Home Run Record
Miami’s Giancarlo Stanton Sets Marlins Home Run Record
Bryce Harper Latest Star to Suffer Injury
Bryce Harper Latest Star to Suffer Injury
Chicago Cubs Must Survive Without Willson Contreras
Chicago Cubs Must Survive Without Willson Contreras
Cleveland Indians Acquire Jay Bruce From New York Mets
Cleveland Indians Acquire Jay Bruce From New York Mets
Injury to CC Sabathia Adds to Yankees’ Concerns
Injury to CC Sabathia Adds to Yankees’ Concerns
Darren Daulton Former Catcher with Phillies Dies
Darren Daulton Former Catcher with Phillies Dies


Leave a Reply

 
© 2006-2017 BBNS.